|
Sign In to gain access to subscriptions and/or personal tools.
|
Essential Tremor
Jack J. Chen, PharmD, BCPS, CGP
Schools of Medicine and Pharmacy, Loma Linda University, Loma Linda, California, jjchen{at}llu.edu
David M. Swope, MD
Department of Neurology and School of Medicine, Loma Linda University, Loma Linda, California
Essential tremor is a common movement disorder that interferes with the performance of motor tasks and social activities. As a consequence, patients experience a reduction in quality of life. The pathophysiology remains not well understood. Differentiation of essential tremor from other tremor syndromes is important in order for clinicians to better provide patient education and therapy. When pharmacotherapy is indicated, the standard agents remain propranolol and primidone. However, additional agents such as benzodiazepines, gabapentin, topiramate, and zonisamide may provide additional symptomatic benefits. Surgical interventions, such as thalamic deep brain stimulation, and focal injections of botulinum toxin offer patients an alternative treatment modality when oral pharmacotherapy is inadequate. A treatment outline is provided to guide clinicians in the management of patients with essential tremor.
Key Words: Essential tremor • movement disorder • pharmacotherapy.
References
Lorenz D., Deuschl G. Update on pathogenesis and treatment of essential tremor. Curr Opin Neurol. 2007;20:447-442.[CrossRef][Medline]
[Order article via Infotrieve] Elbe RJ Report from a U.S. conference on essential tremor. Mov Disord. 2006;21:2052-2061.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve] Nguyen HV, Ngian V., Cordato D., Shen Q., Chan DK Quality of life in a random sample of community dwelling older patients with essential tremor. Acta Neurol Scand. 2007;116:289-292.[CrossRef][Medline]
[Order article via Infotrieve] Jain S., Lo SE, Louis ED Common misdiagnosis of a common neurological disorder: how are we misdiagnosing essential tremor? Arch Neurol. 2006;63:1100-1104.[Abstract/Free Full Text] Elbe RJ Central mechanisms of tremor. J Clin Neurophysiol. 1996;13:133-144.[Web of Science][Medline]
[Order article via Infotrieve] Findley LJ Classification of tremors. J Clin Neurophysiol. 1996;13:122-132.[Web of Science][Medline]
[Order article via Infotrieve] Findley LJ, Koller WC Definitions and behavioral classifications. In: Findley LJ, Koller WC. eds. Handbook of Tremor Disorders. New York, NY: Marcel Dekker; 1995:1-5. Deuschl G., Bain P., Brin M. Consensus statement of the Movement Disorders Society on tremor. Mov Disord. 1998; 13(suppl 3):2-23.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve] Louis ED, Ottman R. Study of possible factors associated with age of onset in essential tremor. Mov Disord. 2006;21: 1980-1986.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve] Salemi G., Savettieri G., Rocca WA, et al. Prevalence of essential tremor: a door-to-door survey in Terrasina, Sicily. Neurology. 1994;44:61-64.[Abstract/Free Full Text] Louis ED, Marder K., Cote L., et al. Differences in the prevalence of essential tremor among elderly African Americans, whites, and Hispanics in northern Manhattan, NY. Arch Neurol. 1995;52:1201-1205.[Abstract/Free Full Text] Deuschl G., Elble RJ The pathophysiology of essential tremor. Neurology. 2000;54(suppl 4):S14-S20.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve] Jenkins IH, Bain PG, Colebatch JG, et al. A positron emission tomography study of essential tremor: evidence for overactivity of cerebellar connections. Ann Neurol. 1993;34:82-90.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve] Mally J., Baranyi M., Vizi ES Change in the concentrations of amino acids in CSF and serum of patients with essential tremor. J Neural Transm. 1996;103:555-560.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve] Boecker H., Koepp M., Turjanski N., et al. Alterations of thalamic GABAa receptor binding in essential tremor. Eur J Neurol. 1996;3(suppl 5):173. Rajput AH, Hornykiewicz O., Deng Y., et al. Biochemical studies of essential tremor brain. Presented at the 14th International Congress on Parkinson's Disease, Helsinki, Finland, July 28-August 1, 2001. Rehman HU Diagnosis and management of tremor. Arch Intern Med. 2000;160:2438-2444.[Abstract/Free Full Text] Deng H., Le W., Jankovic J. Genetics of essential tremor. Brain.2007;130:1456-1464.[Abstract/Free Full Text] Bain PG, Findley LJ, Thompson PD, et al. A study of hereditary essential tremor. Brain.1994;117:805-824.[Abstract/Free Full Text] Louis ED, Barnes L., Wendt KJ, et al. A teaching videotape for the assessment of essential tremor. Mov Disord. 2001;16:89-93[CrossRef][Web of Science][Medline]
[Order article via Infotrieve] Louis ED, Barnes LF, Wendt KJ, et al. Validity and test-retest reliability of a disability questionnaire for essential tremor. Mov Disord. 2000;15:516-523.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve] Barbeau A. Treatment du tremblement essential familial par le propranolol. Union Med Can. 1962;102:899-902. Zesiewicz TA, Elble R., Louis ED, et al. Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2005;64:2008-2020.[Abstract/Free Full Text] Koller WC, Vetere-Overfield B. Acute and chronic effects of propranolol and primidone in essential tremor. Neurology. 1989;39:1587-1588.[Abstract/Free Full Text] Calzetti S., Findley LJ, Pisani F., et al. Phenylethylmalonamide in essential tremor: a double blind controlled study. J Neurol Neurosurg Psychiatry. 1981;44:932-934.[Abstract/Free Full Text] Findley LJ, Cleeves L., Calzetti S. Primidone in essential tremor of the hands and head: a double blind controlled clinical study. J Neurol Neurosurg Psychiatry. 1985;48:911-915.[Abstract/Free Full Text] Pahwa R., Lyons K., Hubble JP, et al. Double-blind controlled trial of gabapentin in essential tremor. Mov Disord. 1998; 13:465-467.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve] Gironell A., Kulisevsky J., Barbanoj M., López-Villegas D., Hernández G., Pascual-Sedano B. A randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremor. Arch Neurol. 1999;56:475-480.[Abstract/Free Full Text] Ondo W., Hunter C., Vuong KD, Schwartz K., Jankovic J. Gabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trial. Mov Disord. 2000;15:678-682.[CrossRef][Medline]
[Order article via Infotrieve] Connor GS A double-blind placebo-controlled trial of topiramte treatment for essential tremor. Neurology. 2002;59:132-134.[Abstract/Free Full Text] Ondo WG, Jankovic J., Connor GS, et al. Topiramate in essential tremor: a double-blind, placebo-controlled trial. Neurology. 2006;66:672-677.[Abstract/Free Full Text] Frima N., Grunewald RA A double-blind, placebo-controlled, crossover trial of topiramate in essential tremor. Clin Neuropharmacol. 2006;29:94-96.[CrossRef][Medline]
[Order article via Infotrieve] Morita S., Miwa H., Kondo T. Effect of zonisamide on essential tremor: a pilot crossover study in comparison with arotinolol. Parkinsonism Relat Disord. 2005;11:101-103.[Medline]
[Order article via Infotrieve] Zesiewicz TA, Ward CL, Hauser RA, Sanchez-Ramos J., Staffetti JF, Sullivan KL A double-blind placebo-controlled trial of zonisamide (Zonegran) in the treatment of essential tremor. Mov Disord. 2007;22:279-282.[CrossRef][Medline]
[Order article via Infotrieve] Zesiewicz TA, Ward CL, Hauser RA, et al. A pilot, double-blind, placebo-controlled trial of pregabalin (Lyrica) in the treatment of essential tremor. Mov Disord. 2007;22:1660-1663.[CrossRef][Medline]
[Order article via Infotrieve] Lou JS, Jankovic J. Essential tremor: clinical correlates in 350 patients. Neurology. 1991;41:234-238.[Abstract/Free Full Text] Boecker H., Wills AJ, Ceballos-Baumann A., et al. The effect of ethanol on alcohol-responsive essential tremor: a positron emission tomography study. Ann Neurol. 1996;39:650-658.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve] Guan XM, Peroutka SJ Basic mechanisms of action of drugs used in the treatment of essential tremor. Clin Neuropharm. 1990;13:210-223.[Medline]
[Order article via Infotrieve] Papa SM, Gershanik OS Orthostatic tremor: an essential tremor variant. Mov Disord. 1988;3:97-108.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve] Singh BR Botulinum neurotoxin structure, engineering, and novel cellular trafficking and targeting. Neurotox Res. 2006;9:73-92.[Medline]
[Order article via Infotrieve] Espay AJ, Mandybur GT, Revilla FJ Surgical treatment of movement disorders. Clin Geriatr Med. 2006;22:813-825.[CrossRef][Medline]
[Order article via Infotrieve] Liu Y., Postupna N., Falkenberg J., Anderson ME High frequency deep brain stimulation: what are the therapeutic mechanisms? Neurosci Biobehav Rev. 2006 doi:10.1016/j. neubiorev.2006.10.007. Hariz GM, Lindberg M., Bergenheim AT Impact of thalamic deep brain stimulation on disability and health-related quality of life in patients with essential tremor. J Neurol Neurosurg Psychiatry. 2002;72:47-52.[Abstract/Free Full Text] Blomstedt P. Hariz GM, Hariz MI, et al. Thalamic deep brain stimulation in the treatment of essential tremor: a long-term follow-up. Br J Neurosurg. 2007;21:504-509.[Medline]
[Order article via Infotrieve]
Journal of Pharmacy Practice, Vol. 20, No. 6,
458-468 (2007)
DOI: 10.1177/0897190007311453
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
|
|
